Lingeng Lu

11.9k total citations · 1 hit paper
193 papers, 6.8k citations indexed

About

Lingeng Lu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lingeng Lu has authored 193 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 56 papers in Cancer Research and 53 papers in Oncology. Recurrent topics in Lingeng Lu's work include Cancer-related molecular mechanisms research (28 papers), RNA modifications and cancer (22 papers) and Epigenetics and DNA Methylation (16 papers). Lingeng Lu is often cited by papers focused on Cancer-related molecular mechanisms research (28 papers), RNA modifications and cancer (22 papers) and Epigenetics and DNA Methylation (16 papers). Lingeng Lu collaborates with scholars based in United States, China and Italy. Lingeng Lu's co-authors include Herbert Yu, Dionyssios Katsaros, Harvey A. Risch, Yingqun Huang, Irene A. Rigault de la Longrais, Lei Yan, Amanda N. Kallen, Mark Kidd, Jie Xu and Michael E. Hume and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Lingeng Lu

188 papers receiving 6.7k citations

Hit Papers

The Imprinted H19 LncRNA Antagonizes Let-7 MicroRNAs 2013 2026 2017 2021 2013 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingeng Lu United States 45 3.8k 2.8k 1.2k 521 480 193 6.8k
Lei Chen China 35 3.7k 1.0× 1.7k 0.6× 639 0.5× 507 1.0× 368 0.8× 165 5.7k
Fen Wang China 43 3.6k 0.9× 1.2k 0.4× 1.2k 1.0× 677 1.3× 969 2.0× 277 7.5k
Zhiyong Zhang China 41 3.3k 0.9× 1.7k 0.6× 844 0.7× 368 0.7× 429 0.9× 268 6.7k
Chen‐Yang Shen Taiwan 43 3.6k 0.9× 1.4k 0.5× 1.4k 1.2× 400 0.8× 457 1.0× 233 6.3k
Chang Yin Liang China 38 2.5k 0.6× 1.4k 0.5× 690 0.6× 809 1.6× 1.3k 2.7× 350 5.8k
Stefano Landi Italy 46 2.9k 0.8× 1.8k 0.7× 1.4k 1.1× 811 1.6× 650 1.4× 245 6.8k
Dirk Reinhardt Germany 60 4.3k 1.1× 1.3k 0.5× 1.8k 1.5× 350 0.7× 1.2k 2.5× 452 11.6k
Jeff M.P. Holly United Kingdom 50 2.9k 0.7× 1.3k 0.5× 1.4k 1.1× 521 1.0× 616 1.3× 202 7.3k
Piotr Dzięgiel Poland 36 2.6k 0.7× 1.1k 0.4× 1.8k 1.5× 573 1.1× 937 2.0× 424 6.2k
Rong Zhong China 37 2.4k 0.6× 1.0k 0.4× 893 0.7× 454 0.9× 453 0.9× 187 4.6k

Countries citing papers authored by Lingeng Lu

Since Specialization
Citations

This map shows the geographic impact of Lingeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingeng Lu more than expected).

Fields of papers citing papers by Lingeng Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingeng Lu. The network helps show where Lingeng Lu may publish in the future.

Co-authorship network of co-authors of Lingeng Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingeng Lu. A scholar is included among the top collaborators of Lingeng Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingeng Lu. Lingeng Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Fubin, Huihong Zhang, Lingeng Lu, et al.. (2025). Early‐Life Exposure to Bisphenol A Damaged Pancreas That May Increase Offspring Sensitivity to High‐Fat Diets. Journal of Toxicology. 2025(1). 6189790–6189790.
4.
Han, Rui, et al.. (2023). CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment. Frontiers in Immunology. 14. 1052657–1052657. 7 indexed citations
5.
Zeng, Hongmei, Fei Ma, John S. Ji, et al.. (2023). Disparities in stage at diagnosis among breast cancer molecular subtypes in China. Cancer Medicine. 12(9). 10865–10876. 3 indexed citations
6.
Li, Huizhang, Guoshuang Feng, Siwei Zhang, et al.. (2023). Disparities in stage at diagnosis for liver cancer in China. SHILAP Revista de lepidopterología. 3(1). 7–13. 11 indexed citations
7.
Han, Rui, Yuqian Wang, & Lingeng Lu. (2023). Sensitizing the Efficiency of ICIs by Neoantigen mRNA Vaccines for HCC Treatment. Pharmaceutics. 16(1). 59–59. 5 indexed citations
8.
Cartmel, Brenda, Fangyong Li, Yang Zhou, et al.. (2023). Randomized trial of exercise on cancer‐related blood biomarkers and survival in women with ovarian cancer. Cancer Medicine. 12(14). 15492–15503. 6 indexed citations
9.
Bade, Brett C., Geliang Gan, Fangyong Li, et al.. (2021). “Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”. BMC Cancer. 21(1). 352–352. 39 indexed citations
10.
Wu, Yixing, Hongmei Zeng, Qing Yu, et al.. (2021). A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study. Cancers. 13(11). 2565–2565. 13 indexed citations
11.
Lv, Peng, et al.. (2020). Meta-analysis of the clinicopathological significance of miRNA-145 in breast cancer. Bioscience Reports. 40(9). 15 indexed citations
12.
Xu, Run, et al.. (2018). Chronic low-dose exposure of nonylphenol alters energy homeostasis in the reproductive system of female rats. Toxicology and Applied Pharmacology. 348. 67–75. 28 indexed citations
13.
Yao, Yongcheng, Xia Gao, Zhen An, et al.. (2018). General self-efficacy modifies the effect of stress on burnout in nurses with different personality types. BMC Health Services Research. 18(1). 667–667. 99 indexed citations
15.
Zhang, J, Lin Liao, Jinming Zhu, et al.. (2018). Osteochondral Interface Stiffening in Mandibular Condylar Osteoarthritis. Journal of Dental Research. 97(5). 563–570. 48 indexed citations
16.
Yang, Hongxu, M. Zhang, Jing Zhang, et al.. (2018). Calcium‐/calmodulin‐dependent protein kinase II in occlusion‐induced degenerative cartilage of rat mandibular condyle. Journal of Oral Rehabilitation. 45(6). 442–451. 17 indexed citations
17.
Wu, Jing, Yi Yang, Chengjun Sun, et al.. (2017). Disruption of the gaa Gene in Zebrafish Fails to Generate the Phenotype of Classical Pompe Disease. DNA and Cell Biology. 36(1). 10–17. 7 indexed citations
18.
Risch, Harvey A., Lingeng Lu, Jing Wang, et al.. (2016). Aspirin Use and Reduced Risk of Pancreatic Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(1). 68–74. 50 indexed citations
19.
Zhu, Gongjian, Lan Wang, Hongyun Guo, et al.. (2015). DNA Repair Genes XRCC1 and ERCC1 Polymorphisms and the Risk of Sporadic Breast Cancer in Han Women in the Gansu Province of China. Genetic Testing and Molecular Biomarkers. 19(7). 387–393. 9 indexed citations
20.
Lu, Lingeng, Michael E. Hume, & Suresh D. Pillai. (2005). Autoinducer-2–Like Activity on Vegetable Produce and Its Potential Involvement in Bacterial Biofilm Formation on Tomatoes. Foodborne Pathogens and Disease. 2(3). 242–249. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026